Polaryx Therapeutics

@Polaryx777

Polaryx Therapeutics, Inc is a biotech company to develop therapeutic interventions for lysosomal storage disorders

Vrijeme pridruživanja: veljača 2017.

Tweetovi

Blokirali ste korisnika/cu @Polaryx777

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @Polaryx777

  1. 26. velj 2018.

    Polaryx Therapeutics Received Orphan Drug Designation From the European Medicines Agency (EMA) for the Treatment of Neuronal Ceroid Lipofuscinosis With PLX-200. Please go to

    Poništi
  2. 11. pro 2017.

    Polaryx Therapeutics Receives Orphan Drug Designation From the US FDA for the Treatment of Neuronal Ceroid Lipofuscinoses With PLX-100.

    Poništi
  3. 7. kol 2017.

    Polaryx Therapeutics, Inc has been granted Orphan Drug Designation from the U.S. FDA for PLX-200 to treat LINCL

    Poništi
  4. 5. velj 2017.

    Just setting up my Twitter.

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·